Cargando…

Letter comments on: “Twelve years of European cancer drug approval—a systematic investigation of the ‘magnitude of clinical benefit’”

Detalles Bibliográficos
Autores principales:	Müller, B., Estay, R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092263/ https://www.ncbi.nlm.nih.gov/pubmed/35525185 http://dx.doi.org/10.1016/j.esmoop.2022.100487

Ejemplares similares

Twelve years of European cancer drug approval—a systematic investigation of the ‘magnitude of clinical benefit’
por: Grössmann, N., et al.
Publicado: (2021)

Twelve Letters, with Remarks
Publicado: (1873)

Letter to the Editor: Comment on Predatory Journals
por: Jawad, Fatema
Publicado: (2017)

Time from US Food and Drug Administration approval to publication of data for cancer drugs: a comparison of first and subsequent approvals
por: Lammers, Austin, et al.
Publicado: (2017)

Letter to the Editor: Epidemiological Comments on the Effectiveness of the Varicella Vaccine in Korea
por: Choi, BongKyoo, et al.
Publicado: (2020)

Contemporary oncology trials, drug approvals and the physician-patient relationship
por: Schnog, John-John B., et al.
Publicado: (2022)

Letter comments on: Drug–drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of patients with metastatic breast cancer
por: Altundag, Kadri
Publicado: (2022)

Hospitals and Approved Societies
por: Dunstan, S.
Publicado: (1923)

Letter comments on: Glomerular filtration rate estimation for carboplatin dosing in patients with gynaecological cancers
por: Cartwright, D., et al.
Publicado: (2022)

I-ACT for Children: helping close the gap in drug approval for adults and children
por: Coppes, Max J., et al.
Publicado: (2022)

Comment on ‘Does bariatric surgery really benefit patients before total knee arthroplasty? a systematic review and meta-analysis’
por: Chen, Xing
Publicado: (2023)

Letter commenting on “Ultrasound evaluation of inferior vena cava compression in tilted and supine term parturients”
por: Massoth, Christina, et al.
Publicado: (2021)

Approved Societies and Hospital Treatment
por: Squires, F.
Publicado: (1922)

Approved Societies and Hospital Treatment
por: Squires, F.
Publicado: (1922)

Approved Societies and Hospital Treatment
por: Michelli, P. J.
Publicado: (1922)

Are Quality of Randomized Clinical Trials and ESMO-Magnitude of Clinical Benefit Scale Two Sides of the Same Coin, to Grade Recommendations for Drug Approval?
por: Rodriguez, Adela, et al.
Publicado: (2021)

Response to letter entitled: letter comments on: Pathologist-initiated reflex testing for biomarkers in non-small-cell lung cancer: expert consensus on the rationale and considerations for implementation
por: Gosney, J.R., et al.
Publicado: (2023)

Efficacy of smallpox approved tecovirimat (Tpoxx) drug against Monkeypox: current update and futuristic prospects
por: Das, Tuyelee, et al.
Publicado: (2023)

Proposed Changes in the Physicians’ Mutual Benefit Association of Texas: Letter from Dr. Vellum
por: Vollum, E. P.
Publicado: (1888)

Twelve years old: the European Federation of Psychiatric Trainees (EFPT)
por: Beezhold, Julian
Publicado: (2005)

Edinburgh Royal Infirmary and Approved Societies
por: Caw, Wm. S.
Publicado: (1922)

Section 12 approval: fit for purpose?
por: Gupta, Nidhi, et al.
Publicado: (2020)

Section 12 approval: fit for purpose?
por: Ballantyne-Watts, Darryl
Publicado: (2020)

Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13
por: Davis, Courtney, et al.
Publicado: (2017)

Reply to ‘Comment on “Tumour-agnostic drugs in paediatric cancers”’
por: Chisholm, Julia C., et al.
Publicado: (2020)

Proposed Changes in the Physicians’ Mutual Benefit Association: Letter from Dr. Samuel A. Stone
por: Stone, Samuel A.
Publicado: (1888)

Predictors of orphan drug approval in the European Union
por: Heemstra, Harald E., et al.
Publicado: (2008)

Pre‐approval and post‐approval availability of evidence and clinical benefit of conditionally approved cancer drugs in Europe: A comparison with standard approved cancer drugs
por: Bloem, Lourens T., et al.
Publicado: (2022)

Do the Approved Societies Seek to Control the Doctors?
por: Ward, Gordon
Publicado: (1922)

Research approvals iceberg: helping it melt away
por: Kolstoe, Simon E., et al.
Publicado: (2019)

Letter comments on: Cosmetic tourism during the COVID-19 pandemic: Dealing with the aftermath
por: McCrossan, S., et al.
Publicado: (2022)

Clinically meaningful benefit: real world use compared against the American and European guidelines
por: Dreicer, Jessica J., et al.
Publicado: (2017)

Health benefits of decarbonization: The transition of carbon intensive regions in the frame of european green deal
por: Emiliano, Michele, et al.
Publicado: (2022)

Comments about the appraisal of systematic reviews in restorative dentistry
por: Afrashtehfar, Kelvin I., et al.
Publicado: (2022)

Letter commenting on ‘The role of experience level in radiographic evaluation of femoroacetabular impingement and acetabular dysplasia’ by Patrick C. Schottel et al.
por: Sampson, Thomas
Publicado: (2015)

Letter to the Editor: Comments on “Association between the ICAM-1 gene polymorphism and coronary heart disease risk: a meta-analysis”
por: Gholami, Morteza, et al.
Publicado: (2019)

Reply to letter commenting on “Cosmetic tourism during the COVID-19 pandemic: Dealing with the aftermath”
por: Varma, Parvathi, et al.
Publicado: (2022)

Clinical Benefit and Expedited Approval of Cancer Drugs in the United States, European Union, Switzerland, Japan, Canada, and Australia
por: Hwang, Thomas J., et al.
Publicado: (2022)

Response to letter to the editor PD‐17‐0390, a comment on “Comparing methods for fetal fraction determination and quality control of NIPT samples”
por: van Beek, Daphne M., et al.
Publicado: (2017)

Drugs and Devices: Comparison of European and U.S. Approval Processes
por: Van Norman, Gail A.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_p676t9ko09mh1c53ekm7rguje1